Research Funding Available from the BLF
30 November 2011
The British Lung Foundation is happy to announce availability of the 2nd year of research funding of their 3-year Asbestos-Related Diseases initiative.
The BLF’s Asbestos-related Diseases Advisory Group has selected four priority areas for funding in the 2nd year of this scheme. New applications must focus on one or more of the following priority areas:
(i) a stratified medicine approach based on targeting therapy on the molecular basis of asbestos-related diseases or biomarkers.
(ii) collaborations with pharmaceutical companies to develop new therapeutic agents for asbestos-related diseases.
(iii) collaborative projects that involve other organisations and/or funding bodies outside the UK (including clinical, laboratory and/or epidemiological research). (Please note that the BLF cannot fund research institutions outside of the UK. A principal investigator must therefore be based at a UK institution, although co-applicants can be based abroad).
(iv) novel approaches to support or palliative care for individuals with asbestos-related disease.
Awards are available in the form of pump-priming grants (up to £25,000), project grants of up to 3 years (up to £200,000) and PhD studentships (£100,000). Deadlines for application submission are:
24 February 2012 - Project Grants and PhDs.
27 April 2012 - Pump Priming Grants.
For full information and to download application forms and guidelines, please see the BLF website: http://www.lunguk.org/research_and_grants/grants_available_how_to_apply
A total of £850k is available in this round. Applicants will be notified of funding decisions by the end of June 2012.
Pages in this section
Find a course
News
We currently have the following vacancy within our organisation: Academic Lead
We are delighted to announce this exciting opportunity for a suitably qualified healthcare professional.
Education for Health welcomes the NHS Companion Document for the COPD & Asthma Outcomes Strategy - Launched Today
Improving outcomes for people with Respiratory Disease is a key priority for the NHS. To support the Outcomes Strategy for COPD and Asthma, published last July, a companion document has been published that sets out 46 key actions for the NHS.
- more news



